Weight Management • Appetite Control • Metabolic Support
Weight Management • Appetite Control • Metabolic Support
IPHARMA Tirzepatide 30mg / 2.4ml is a compounded peptide pen formulation designed for precision dosing and ease of use in advanced research applications. This pre-filled pen format is engineered for consistency, stability, and controlled delivery, making it suitable for structured laboratory and metabolic research environments.
Tirzepatide is commonly associated with dual GLP-1 and GIP receptor agonist activity and is widely researched in relation to metabolic function, glucose regulation pathways, appetite control, and energy balance mechanisms. The pen system supports accurate and repeatable dosing protocols within controlled research settings.
Key Benefits
- Dual GLP-1 and GIP receptor agonist compound commonly researched in metabolic studies
- May support appetite regulation and satiety-related research models
- Frequently explored in weight management and glucose metabolism research contexts
- Designed for consistent, controlled, and repeatable delivery in research use
- Long-acting peptide profile suitable for extended research applications
- Stable formulation intended for reliable handling and storage
- Suitable for advanced laboratory and metabolic research workflows.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
